CAR-T Cell Immunotherapy Market Report

China CAR-T Cell Immunotherapy Industry Market Research Report 2023-2029

  • POSTDATE：Sep 17, 2023
  • PAGES：143
  • REPORT CODE：GMM1805246
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the CAR-T Cell Immunotherapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • CARsgen Therapeutics, Ltd

    • Pfizer, Inc

    • Genscript Biotech Corporation

    • Mustang Bio, Inc

    • Novartis International AG

    • Gilead Sciences, Inc

    • Sorrento Therapeutics Inc

    • Aurora Biopharma Inc

    By Type:

    • CD19/CD22

    • Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY)

    • BCMA (B-Cell Maturation Antigen)

    By Application:

    • Chronic Lymphocytic Leukemia (CLL)

    • Follicular Lymphoma (FL)

    • Acute Lymphoblastic Leukemia (ALL)

    • Multiple Myeloma (MM)

    • Others

    • Diffuse Large B-Cell Lymphoma (DLBCL)

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China CAR-T Cell Immunotherapy Market Overview 2018-2029

    • 1.1 China CAR-T Cell Immunotherapy Industry Development Overview

    • 1.2 China CAR-T Cell Immunotherapy Industry Development History

    • 1.3 China CAR-T Cell Immunotherapy Industry Market Size (2018-2029)

    • 1.4 China CAR-T Cell Immunotherapy Market Analysis by Type from Production Side

      • 1.4.1 China CAR-T Cell Immunotherapy Production Volume, Production Value and Growth Rate of CD19/CD22 (2018-2029)

      • 1.4.2 China CAR-T Cell Immunotherapy Production Volume, Production Value and Growth Rate of Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY) (2018-2029)

      • 1.4.3 China CAR-T Cell Immunotherapy Production Volume, Production Value and Growth Rate of BCMA (B-Cell Maturation Antigen) (2018-2029)

    • 1.5 China CAR-T Cell Immunotherapy Market Analysis by Application from Consumption End

      • 1.5.1 China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Chronic Lymphocytic Leukemia (CLL) (2018-2029)

      • 1.5.2 China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Follicular Lymphoma (FL) (2018-2029)

      • 1.5.3 China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2018-2029)

      • 1.5.4 China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Multiple Myeloma (MM) (2018-2029)

      • 1.5.5 China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.6 China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Diffuse Large B-Cell Lymphoma (DLBCL) (2018-2029)

    • 1.6 China CAR-T Cell Immunotherapy Market Analysis by Region

      • 1.6.1 North China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    Chapter 2 China CAR-T Cell Immunotherapy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on CAR-T Cell Immunotherapy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China CAR-T Cell Immunotherapy Market Status and Competition Analysis in 2023

      • 2.2.3 China CAR-T Cell Immunotherapy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China CAR-T Cell Immunotherapy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on CAR-T Cell Immunotherapy Industry Development

    Chapter 3 CAR-T Cell ImmunotherapyIndustry Chain Analysis

    • 3.1 CAR-T Cell Immunotherapy Industry Chain

    • 3.2 CAR-T Cell Immunotherapy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the CAR-T Cell Immunotherapy Market

    • 3.3 CAR-T Cell Immunotherapy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the CAR-T Cell Immunotherapy Market

    Chapter 4 China CAR-T Cell Immunotherapy Market, by Type

    • 4.1 China CAR-T Cell Immunotherapy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China CAR-T Cell Immunotherapy Total Production Volume and Growth Rate from Production Side

    • 4.5 China CAR-T Cell Immunotherapy Production Volume and Growth Rate, by Type

      • 4.5.1 China CAR-T Cell Immunotherapy Production Volume and Growth Rate of CD19/CD22

      • 4.5.2 China CAR-T Cell Immunotherapy Production Volume and Growth Rate of Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY)

      • 4.5.3 China CAR-T Cell Immunotherapy Production Volume and Growth Rate of BCMA (B-Cell Maturation Antigen)

    Chapter 5 China CAR-T Cell Immunotherapy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China CAR-T Cell Immunotherapy Total Market Size and Growth Rate from Consumption End

    • 5.5 China CAR-T Cell Immunotherapy Market Size and Growth Rate, by Application

      • 5.5.1 China CAR-T Cell Immunotherapy Market Size and Growth Rate of Chronic Lymphocytic Leukemia (CLL)

      • 5.5.2 China CAR-T Cell Immunotherapy Market Size and Growth Rate of Follicular Lymphoma (FL)

      • 5.5.3 China CAR-T Cell Immunotherapy Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL)

      • 5.5.4 China CAR-T Cell Immunotherapy Market Size and Growth Rate of Multiple Myeloma (MM)

      • 5.5.5 China CAR-T Cell Immunotherapy Market Size and Growth Rate of Others

      • 5.5.6 China CAR-T Cell Immunotherapy Market Size and Growth Rate of Diffuse Large B-Cell Lymphoma (DLBCL)

    Chapter 6 China CAR-T Cell Immunotherapy Market, by Region

    • 6.1 China CAR-T Cell Immunotherapy Production Volume and Production Value, by Region

    • 6.2 China CAR-T Cell Immunotherapy Sales Volume and Sales Value, by Region

    Chapter 7 North China CAR-T Cell Immunotherapy Market Analysis

    • 7.1 North China CAR-T Cell Immunotherapy Market, by Type

    • 7.2 North China CAR-T Cell Immunotherapy Market, by Application

    Chapter 8 Central China CAR-T Cell Immunotherapy Market Analysis

    • 8.1 Central China CAR-T Cell Immunotherapy Market, by Type

    • 8.2 Central China CAR-T Cell Immunotherapy Market, by Application

    Chapter 9 South China CAR-T Cell Immunotherapy Market Analysis

    • 9.1 South China CAR-T Cell Immunotherapy Market, by Type

    • 9.2 South China CAR-T Cell Immunotherapy Market, by Application

    Chapter 10 East China CAR-T Cell Immunotherapy Market Analysis

    • 10.1 East China CAR-T Cell Immunotherapy Market, by Type

    • 10.2 East China CAR-T Cell Immunotherapy Market, by Application

    Chapter 11 Northeast China CAR-T Cell Immunotherapy Market Analysis

    • 11.1 Northeast China CAR-T Cell Immunotherapy Market, by Type

    • 11.2 Northeast China CAR-T Cell Immunotherapy Market, by Application

    Chapter 12 Southwest China CAR-T Cell Immunotherapy Market Analysis

    • 12.1 Southwest China CAR-T Cell Immunotherapy Market, by Type

    • 12.2 Southwest China CAR-T Cell Immunotherapy Market, by Application

    Chapter 13 Northwest China CAR-T Cell Immunotherapy Market Analysis

    • 13.1 Northwest China CAR-T Cell Immunotherapy Market, by Type

    • 13.2 Northwest China CAR-T Cell Immunotherapy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 CARsgen Therapeutics, Ltd

        • 14.1.1 CARsgen Therapeutics, Ltd Company Profile

        • 14.1.2 CARsgen Therapeutics, Ltd CAR-T Cell Immunotherapy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer, Inc

        • 14.2.1 Pfizer, Inc Company Profile

        • 14.2.2 Pfizer, Inc CAR-T Cell Immunotherapy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Genscript Biotech Corporation

        • 14.3.1 Genscript Biotech Corporation Company Profile

        • 14.3.2 Genscript Biotech Corporation CAR-T Cell Immunotherapy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Mustang Bio, Inc

        • 14.4.1 Mustang Bio, Inc Company Profile

        • 14.4.2 Mustang Bio, Inc CAR-T Cell Immunotherapy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Novartis International AG

        • 14.5.1 Novartis International AG Company Profile

        • 14.5.2 Novartis International AG CAR-T Cell Immunotherapy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Gilead Sciences, Inc

        • 14.6.1 Gilead Sciences, Inc Company Profile

        • 14.6.2 Gilead Sciences, Inc CAR-T Cell Immunotherapy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Sorrento Therapeutics Inc

        • 14.7.1 Sorrento Therapeutics Inc Company Profile

        • 14.7.2 Sorrento Therapeutics Inc CAR-T Cell Immunotherapy Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Aurora Biopharma Inc

        • 14.8.1 Aurora Biopharma Inc Company Profile

        • 14.8.2 Aurora Biopharma Inc CAR-T Cell Immunotherapy Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 CAR-T Cell Immunotherapy Industry Research Conclusions

    • 15.2 CAR-T Cell Immunotherapy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China CAR-T Cell Immunotherapy Industry Market Size (2018-2029)

    • Figure China CAR-T Cell Immunotherapy Production Volume, Production Value and Growth Rate of CD19/CD22 (2018-2029)

    • Figure China CAR-T Cell Immunotherapy Production Volume, Production Value and Growth Rate of Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY) (2018-2029)

    • Figure China CAR-T Cell Immunotherapy Production Volume, Production Value and Growth Rate of BCMA (B-Cell Maturation Antigen) (2018-2029)

    • Figure China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Chronic Lymphocytic Leukemia (CLL) (2018-2029)

    • Figure China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Follicular Lymphoma (FL) (2018-2029)

    • Figure China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2018-2029)

    • Figure China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Multiple Myeloma (MM) (2018-2029)

    • Figure China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China CAR-T Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Diffuse Large B-Cell Lymphoma (DLBCL) (2018-2029)

    • Figure North China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Central China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure South China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure East China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China CAR-T Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure CAR-T Cell Immunotherapy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China CAR-T Cell Immunotherapy Market Share by Type in 2018

    • Figure China CAR-T Cell Immunotherapy Market Share by Type in 2023

    • Figure China CAR-T Cell Immunotherapy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Production Volume and Growth Rate of CD19/CD22 (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Production Volume and Growth Rate of Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY) (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Production Volume and Growth Rate of BCMA (B-Cell Maturation Antigen) (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Market Share by Application in 2018

    • Figure China CAR-T Cell Immunotherapy Market Share by Application in 2023

    • Figure China CAR-T Cell Immunotherapy Total Market Size and Growth Rate from Consumption End

    • Figure China CAR-T Cell Immunotherapy Market Size and Growth Rate of Chronic Lymphocytic Leukemia (CLL) (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Market Size and Growth Rate of Follicular Lymphoma (FL) (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Market Size and Growth Rate of Multiple Myeloma (MM) (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Market Size and Growth Rate of Others (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Market Size and Growth Rate of Diffuse Large B-Cell Lymphoma (DLBCL) (2018-2023)

    • Table China CAR-T Cell Immunotherapy Production Volume by Region (2018-2023)

    • Table China CAR-T Cell Immunotherapy Production Volume Share by Region (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Production Volume Share by Region (2018-2023)

    • Table China CAR-T Cell Immunotherapy Production Value by Region (2018-2023)

    • Table China CAR-T Cell Immunotherapy Production Value Share by Region (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Production Value Share by Region (2018-2023)

    • Table China CAR-T Cell Immunotherapy Sales Volume by Region (2018-2023)

    • Table China CAR-T Cell Immunotherapy Sales Volume Share by Region (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Sales Volume Share by Region (2018-2023)

    • Table China CAR-T Cell Immunotherapy Sales Value by Region (2018-2023)

    • Table China CAR-T Cell Immunotherapy Sales Value Share by Region (2018-2023)

    • Figure China CAR-T Cell Immunotherapy Sales Value Share by Region (2018-2023)

    • Table North China CAR-T Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table North China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure North China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table North China CAR-T Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table North China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure North China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Central China CAR-T Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Central China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Central China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Central China CAR-T Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Central China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Central China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table South China CAR-T Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table South China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure South China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table South China CAR-T Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table South China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure South China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table East China CAR-T Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table East China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure East China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table East China CAR-T Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table East China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure East China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Northeast China CAR-T Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Northeast China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Northeast China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Northeast China CAR-T Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Northeast China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Southwest China CAR-T Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Southwest China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Southwest China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Southwest China CAR-T Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Southwest China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Northwest China CAR-T Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Northwest China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Northwest China CAR-T Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Northwest China CAR-T Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Northwest China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China CAR-T Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table CARsgen Therapeutics, Ltd Company Profile

    • Table CARsgen Therapeutics, Ltd CAR-T Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc CAR-T Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Genscript Biotech Corporation Company Profile

    • Table Genscript Biotech Corporation CAR-T Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Mustang Bio, Inc Company Profile

    • Table Mustang Bio, Inc CAR-T Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Novartis International AG Company Profile

    • Table Novartis International AG CAR-T Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences, Inc Company Profile

    • Table Gilead Sciences, Inc CAR-T Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Sorrento Therapeutics Inc Company Profile

    • Table Sorrento Therapeutics Inc CAR-T Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Aurora Biopharma Inc Company Profile

    • Table Aurora Biopharma Inc CAR-T Cell Immunotherapy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US